Merck’s Keytruda is bound for new bladder cancer territory. But can it hold up against gene therapy?

Merck's Keytruda is bound for new bladder cancer territory. But can it hold up against gene therapy?

Η πρώτη θεραπεία που παρατείνει την επιβίωση στον καρκίνο του ήπατος

Η πρώτη θεραπεία που παρατείνει την επιβίωση στον καρκίνο του ήπατος

Roche’s Tecentriq, on an EU hot streak, bags 2 new lung cancer approvals

Roche's Tecentriq, on an EU hot streak, bags 2 new lung cancer approvals

Pfizer Inks Real-World Oncology Data Collaboration With Concerto HealthAI

Pfizer Inks Real-World Oncology Data Collaboration With Concerto HealthAI